<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02071524</url>
  </required_header>
  <id_info>
    <org_study_id>22012014</org_study_id>
    <nct_id>NCT02071524</nct_id>
  </id_info>
  <brief_title>Evaluation of the Effects of Fluid Therapy on Respiratory Mechanics</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi di Ferrara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi di Ferrara</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that large doses of fluids used during intraoperative could
      affect lung parenchyma structure and, consequently, gas exchange and respiratory mechanics.
      The purpose of this study is to evaluate fluids effects on oxygenation, respiratory
      mechanics, by using two different solutions: crystalloid or colloid.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion Criteria:

        -  patients undergoing elective abdominal, thoracic, vascular surgery

        -  minimum age 18 years

        -  informed consent

      Exclusion Criteria:

        -  patients with severe cardiomyopathy or severe heart failure

        -  history of coagulation disorders

        -  patients with severe cardiovascular or respiratory disorders

        -  renal insufficiency

      Respiratory mechanic parameters (i.e., inspiratory peak pressure, plateau pressure, total
      airway resistance, and static compliance) are obtained .Blood samples are drawn
      simultaneously from the arterial catheters for gas analysis. Data were collected after
      induction of anesthesia (T0) after 1 h (T1), 2 h (T2), 3 h (T3) and at the end of surgery.

      Primary outcome: evaluate the fluids effects on oxygenation, respiratory mechanics

      Secondary outcome: Incidence of surgery related complications
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>effects on oxygenation, respiratory mechanics</measure>
    <time_frame>every 30 minutes till the end of surgery</time_frame>
    <description>Lung compliance (l/cmH20), Airaway resistance (cmH2O/L/sec) and PaO2 will be measured</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of respiratory complications</measure>
    <time_frame>28 days</time_frame>
    <description>Complications like acute respiratory failure, pneumonia and ARDS will be recorded</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Mechanical Ventilation Complication</condition>
  <condition>Actual Impaired Fluid Volume</condition>
  <arm_group>
    <arm_group_label>Cristalloid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>group cristalloid (ringer lactate)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>colloids</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>colloid: cristalloid in according to cardiac output</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Group Colloid</intervention_name>
    <description>Group Colloid: cristalloid 1:2 (gelofusine: ringer lactate)</description>
    <arm_group_label>colloids</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cristalloid administration</intervention_name>
    <description>Only Ringer Lactate administration</description>
    <arm_group_label>Cristalloid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing elective abdominal, thoracic, vascular surgery

          -  minimum age 18 years

          -  informed consent

        Exclusion Criteria:

          -  patients with severe cardiomyopathy or severe heart failure

          -  history of coagulation disorders

          -  patients with severe cardiovascular or respiratory disorders

          -  renal insufficiency

          -  severe liver diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Savino Spadaro, researcher</last_name>
    <phone>+390532206570</phone>
    <email>spdsvn@unife.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Ferrara</name>
      <address>
        <city>Ferrara</city>
        <zip>44121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlo A Volta, professor</last_name>
      <phone>+390532206570</phone>
      <email>vlc@unife.it</email>
    </contact>
    <investigator>
      <last_name>Savino Spadaro, Researcher</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2014</study_first_submitted>
  <study_first_submitted_qc>February 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2014</study_first_posted>
  <last_update_submitted>November 7, 2016</last_update_submitted>
  <last_update_submitted_qc>November 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi di Ferrara</investigator_affiliation>
    <investigator_full_name>Savino Spadaro</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

